ADMA BIOLOGICS INC - COMMON STOCK
9.0600
16-May-24 14:59:59
15 minutes delayed
Stocks
-0.0400
-0.44%
Today's range
8.9700 - 9.1567
ISIN
N/A
Source
NASDAQ
-
ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023
01 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months High: ADMA BIOLOGICS INC - COMMON STOCK
15 Aug 2023 13:08:00 By NetDania Notify
-
NetDania - New 12 months High: ADMA BIOLOGICS INC - COMMON STOCK
10 Aug 2023 08:49:00 By NetDania Notify
-
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
09 Aug 2023 15:05:01 By Nasdaq GlobeNewswire
-
ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023
02 Aug 2023 06:00:02 By Nasdaq GlobeNewswire
-
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
19 Jul 2023 06:00:00 By Nasdaq GlobeNewswire
-
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update
10 May 2023 15:05:01 By Nasdaq GlobeNewswire
-
ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023
03 May 2023 06:00:01 By Nasdaq GlobeNewswire
-
ADMA Biologics Announces Amendment to Credit Agreement
02 May 2023 06:00:00 By Nasdaq GlobeNewswire
-
23 Mar 2023 15:05:00 By Nasdaq GlobeNewswire
-
ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023
16 Mar 2023 06:00:01 By Nasdaq GlobeNewswire
-
08 Feb 2023 06:00:00 By Nasdaq GlobeNewswire
-
17 Jan 2023 06:00:00 By Nasdaq GlobeNewswire
-
ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV™ & BIVIGAM®
13 Dec 2022 06:00:00 By Nasdaq GlobeNewswire
-
09 Dec 2022 15:05:00 By Nasdaq GlobeNewswire
-
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
07 Dec 2022 07:45:00 By Nasdaq GlobeNewswire
-
ADMA Biologics Announces Proposed Public Offering of Common Stock
06 Dec 2022 15:05:00 By Nasdaq GlobeNewswire
-
ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate
06 Dec 2022 15:01:00 By Nasdaq GlobeNewswire
-
ADMA Biologics Announces Third Quarter 2022 Financial Results and Provides Business Update
09 Nov 2022 15:05:02 By Nasdaq GlobeNewswire
-
ADMA Biologics to Report Third Quarter 2022 Financial Results on November 9, 2022
02 Nov 2022 06:00:02 By Nasdaq GlobeNewswire